Cargando…

Pericardial NT-Pro-BNP and GDF-15 as Biomarkers of Atrial Fibrillation and Atrial Matrix Remodeling in Aortic Stenosis

Aims: This study aimed to evaluate the association of GDF-15 and NT-pro-BNP in two different biological matrices with AF in severe aortic stenosis patients undergoing aortic valve replacement surgery (AVR), its association with atrial matrix remodeling, as well as with 30-day postoperative outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Fragão-Marques, Mariana, Barroso, Isaac, Farinha, Rui, Miranda, Isabel M, Martins, Diana, Mancio, Jennifer, Rocha-Neves, João, Guimarães, João T, Leite-Moreira, Adelino, Falcão-Pires, Inês
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392313/ https://www.ncbi.nlm.nih.gov/pubmed/34441356 http://dx.doi.org/10.3390/diagnostics11081422

Ejemplares similares

Pericardial Fluid Annexin A1 Is a Marker of Atrial Fibrillation in Aortic Stenosis: A Proteomics Analysis
por: Fragão-Marques, Mariana, et al.
Publicado: (2022)

Gender Differences in Predictors and Long-Term Mortality of New-Onset Postoperative Atrial Fibrillation Following Isolated Aortic Valve Replacement Surgery
por: Fragão-Marques, Mariana, et al.
Publicado: (2020)

Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis
por: Fragão-Marques, Mariana, et al.
Publicado: (2021)

Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis
por: Fragão-Marques, Mariana, et al.
Publicado: (2020)

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2019)

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2020)

Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation
por: Matusik, Paweł T., et al.
Publicado: (2019)

Changes in Serum NT-Pro BNP and Left Atrial BNP Levels after Percutaneous Transvenous Mitral Commissurotomy in Sinus Rhythm Versus Atrial Firilation
por: Pourafkari, Leili, et al.
Publicado: (2014)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
por: Whitman, Isaac R., et al.
Publicado: (2019)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
por: Sieweke, Jan-Thorben, et al.
Publicado: (2020)

NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis
por: Licata, Anna, et al.
Publicado: (2013)

Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide
por: Amin, Ahmad Shoaib, et al.
Publicado: (2015)

Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
por: Almuwaqqat, Zakaria, et al.
Publicado: (2019)

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
por: Staszewsky, Lidia, et al.
Publicado: (2021)

NT Pro‐BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement
por: Zhao, Xiao, et al.
Publicado: (2021)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
por: Chouairi, Fouad, et al.
Publicado: (2021)

Left atrial diameter and atrial fibrillation, but not elevated NT-proBNP, predict the development of pulmonary hypertension in patients with HFpEF
por: LIU, Yi-Xian, et al.
Publicado: (2020)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
por: Kerr, Brian, et al.
Publicado: (2022)

Correlation of NT-proBNP and left atrial pressure in patients with atypical atrial flutter after cardiac surgery and previous catheter ablation
por: Bakytzhanuly, A, et al.
Publicado: (2023)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?
por: Skau, Emma, et al.
Publicado: (2023)

NT-pro-BNP as a Predictor for Recurrence of Atrial Fibrillation after Primary Cryoballoon Pulmonary Vein Isolation
por: Blessberger, Hermann, et al.
Publicado: (2022)

Right atrial volume measured by cardiac magnetic resonance correlates with NT-ProBNP and invasive right atrial pressure in pulmonary hypertension, with and without systemic sclerosis
por: Gyllenhammar, Tom, et al.
Publicado: (2016)

Left atrial stiffness is superior to volume and strain parameters in predicting elevated NT-proBNP levels in systemic sclerosis patients
por: Porpáczy, Adél, et al.
Publicado: (2019)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Baseline NT-Pro-BNP Levels and Arrhythmia Recurrence in Outpatients Undergoing Elective Cardioversion of Persistent Atrial Fibrillation: A Survival Analysis
por: Sanna, Tommaso, et al.
Publicado: (2009)

Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study
por: Diederichsen, S Z, et al.
Publicado: (2023)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Association of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis
por: Mancio, Jennifer, et al.
Publicado: (2017)

Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study
por: Meems, L.M.G., et al.
Publicado: (2022)

Serum Levels of NT-Pro BNP in Patients with Preeclampsia
por: Nguyen, Thanh Xuan, et al.
Publicado: (2022)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy
por: Trindade, Fábio, et al.
Publicado: (2020)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

Serum BNP levels are associated with malignant pericardial effusion
por: Carasso, Shemy, et al.
Publicado: (2019)

Relation between E/e’ ratio and NT-proBNP levels in elderly patients with symptomatic severe aortic stenosis
por: Strachinaru, Mihai, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4coidgknt3ooh4femjql10ar2m